ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Gallo To Give Scripps Symposium’s Schwartz Lecture

August 9, 1985

Study Finds Green Tea No Help In Advanced Prostate Cancer

March 28, 2003

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011

NCI, Groups Disagree Over repayment, McIntyre: NCA Could Examine Relationship of Groups To NCI

December 9, 1994

Pitot Supports Clearinghouse Modifications

January 20, 1978